3
|
Sethiya A, Agarwal DK, Agarwal S. Current Trends in Drug Delivery System of Curcumin and its Therapeutic Applications. Mini Rev Med Chem 2021; 20:1190-1232. [PMID: 32348221 DOI: 10.2174/1389557520666200429103647] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2020] [Revised: 03/30/2020] [Accepted: 04/09/2020] [Indexed: 02/07/2023]
Abstract
Curcumin is a poly phenolic compound extracted from turmeric. Over the past years, it has acquired significant interest among researchers due to its numerous pharmacological activities like anti- cancer, anti-alzheimer, anti-diabetic, anti-bacterial, anti-inflammatory and so on. However, the clinical use of curcumin is still obstructed due to tremendously poor bioavailability, rapid metabolism, lower gastrointestinal absorption, and low permeability through cell that makes its pharmacology thrilling. These issues have led to enormous surge of investigation to develop curcumin nano formulations which can overcome these restrictive causes. The scientists all across the universe are working on designing several drug delivery systems viz. liposomes, micelles, magnetic nano carriers, etc. for curcumin and its composites which not only improve its physiochemical properties but also enhanced its therapeutic applications. The review aims to systematically examine the treasure of information about the medicinal use of curcumin. This article delivers a general idea of the current study piloted to overwhelm the complications with the bioavailability of curcumin which have exhibited an enhanced biological activity than curcumin. This article explains the latest and detailed study of curcumin and its conjugates, its phytochemistry and biological perspectives and also proved curcumin as an efficient drug candidate for the treatment of numerous diseases. Recent advancements and futuristic viewpoints are also deliberated, which shall help researchers and foster commercial translations of improved nanosized curcumin combination for the treatment of various diseases.
Collapse
Affiliation(s)
- Ayushi Sethiya
- Department of Chemistry, Synthetic Organic Chemistry Laboratory, MLS University, Udaipur, 313001, India
| | | | - Shikha Agarwal
- Department of Chemistry, Synthetic Organic Chemistry Laboratory, MLS University, Udaipur, 313001, India
| |
Collapse
|
4
|
Popescu RC, Savu D, Dorobantu I, Vasile BS, Hosser H, Boldeiu A, Temelie M, Straticiuc M, Iancu DA, Andronescu E, Wenz F, Giordano FA, Herskind C, Veldwijk MR. Efficient uptake and retention of iron oxide-based nanoparticles in HeLa cells leads to an effective intracellular delivery of doxorubicin. Sci Rep 2020; 10:10530. [PMID: 32601333 PMCID: PMC7324358 DOI: 10.1038/s41598-020-67207-y] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Accepted: 06/01/2020] [Indexed: 12/12/2022] Open
Abstract
The purpose of this study was to construct and characterize iron oxide nanoparticles (IONPCO) for intracellular delivery of the anthracycline doxorubicin (DOX; IONPDOX) in order to induce tumor cell inactivation. More than 80% of the loaded drug was released from IONPDOX within 24 h (100% at 70 h). Efficient internalization of IONPDOX and IONPCO in HeLa cells occurred through pino- and endocytosis, with both IONP accumulating in a perinuclear pattern. IONPCO were biocompatible with maximum 27.9% ± 6.1% reduction in proliferation 96 h after treatment with up to 200 µg/mL IONPCO. Treatment with IONPDOX resulted in a concentration- and time-dependent decrease in cell proliferation (IC50 = 27.5 ± 12.0 μg/mL after 96 h) and a reduced clonogenic survival (surviving fraction, SF = 0.56 ± 0.14; versus IONPCO (SF = 1.07 ± 0.38)). Both IONP constructs were efficiently internalized and retained in the cells, and IONPDOX efficiently delivered DOX resulting in increased cell death vs IONPCO.
Collapse
Affiliation(s)
- R C Popescu
- "Horia Hulubei" National Institute for Research and Development in Physics and Nuclear Engineering, Department of Life and Environmental Physics, Reactorului 30, 077125, Magurele, Romania.,Politehnica University of Bucharest, Department of Science and Engineering of Oxide Materials and Nanomaterials, Polizu 1-7, 011061, Bucharest, Romania.,Heidelberg University, Medical Faculty Mannheim, Universitätsmedizin Mannheim, Department of Radiation Oncology, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany
| | - D Savu
- "Horia Hulubei" National Institute for Research and Development in Physics and Nuclear Engineering, Department of Life and Environmental Physics, Reactorului 30, 077125, Magurele, Romania.
| | - I Dorobantu
- "Horia Hulubei" National Institute for Research and Development in Physics and Nuclear Engineering, Department of Life and Environmental Physics, Reactorului 30, 077125, Magurele, Romania
| | - B S Vasile
- Politehnica University of Bucharest, Department of Science and Engineering of Oxide Materials and Nanomaterials, Polizu 1-7, 011061, Bucharest, Romania
| | - H Hosser
- Heidelberg University, Medical Faculty Mannheim, Universitätsmedizin Mannheim, Center for Biomedicine and Medical Technology, Department of Anatomy and Developmental Biology, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany
| | - A Boldeiu
- National Institute for Research and Development in Microtechnologies, Laboratory of Nanobiotechnology, Erou Iancu Nicolae 12A, 077190, Bucharest, Romania
| | - M Temelie
- "Horia Hulubei" National Institute for Research and Development in Physics and Nuclear Engineering, Department of Life and Environmental Physics, Reactorului 30, 077125, Magurele, Romania
| | - M Straticiuc
- "Horia Hulubei" National Institute for Research and Development in Physics and Nuclear Engineering, Department of Applied Nuclear Physics, Reactorului 30, 077125, Magurele, Romania
| | - D A Iancu
- "Horia Hulubei" National Institute for Research and Development in Physics and Nuclear Engineering, Department of Applied Nuclear Physics, Reactorului 30, 077125, Magurele, Romania
| | - E Andronescu
- Politehnica University of Bucharest, Department of Science and Engineering of Oxide Materials and Nanomaterials, Polizu 1-7, 011061, Bucharest, Romania
| | - F Wenz
- University Medical Center Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany
| | - F A Giordano
- Heidelberg University, Medical Faculty Mannheim, Universitätsmedizin Mannheim, Department of Radiation Oncology, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany
| | - C Herskind
- Heidelberg University, Medical Faculty Mannheim, Universitätsmedizin Mannheim, Department of Radiation Oncology, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany
| | - M R Veldwijk
- Heidelberg University, Medical Faculty Mannheim, Universitätsmedizin Mannheim, Department of Radiation Oncology, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
| |
Collapse
|